|
|
 |
| |
 |
Permeation Enhancement Technology |
 |
|
| |
The Path to Improved Drug Benefits - Permeation enhancement with CPE-215 is our patented drug
delivery technology. CPE-215 enhances the absorption of drugs across a variety of biological
membranes including the skin, mouth, nose and eye. The technology can be adapted to products
formulated as creams, ointments, gels, solutions, lotions, sprays or patches. CPE-215 also has
maintained a record of safety as a direct and indirect food additive and fragrance, and is listed
on the FDA’s inactive ingredient list for approved use in drug applications. We believe that key
benefits of the patented drug permeation technology of CPEX using CPE-215 may include the following
therapeutic and commercial opportunities and advantages:
- Improved compliance and convenience to patients requiring ongoing injection therapies and the
potential for earlier acceptance of prophylactic treatment for patients reluctant to use injections;
- Application to injectable peptides that could be administered intranasally with CPE-215;
- Application to therapeutic molecules that are degraded by passage through the liver or would benefit
from intra-nasal administration to eliminate first-pass metabolism;
- Application to a variety of metabolic, neurological and other serious medical conditions;
- Opportunities for life-cycle extension strategies for existing marketed products;
- Opportunities for allowing product differentiation based on benefits of administration.
|
|
|
| The information posted is as of 10/02/2009 and, to our knowledge,
was timely and accurate when posted. We are under no obligation to update or remove outdated information
other than as required by applicable law or regulation. |
|
|
|
|
|
|
